{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T16:02:06Z","timestamp":1769097726209,"version":"3.49.0"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T00:00:00Z","timestamp":1545264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To discuss the current knowledge on the impact of commonly used biologic agents (i.e., anti\u2013tumor necrosis factor\u2013alpha [anti-TNF-\u03b1] and anti\u2013nerve growth factor [anti-NGF]) in the management of low back pain with or without sciatica.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A narrative literature review of studies investigating the use of biologic agents for the management of low back pain and sciatica was conducted. We searched MEDLINE and EMBASE for English language publications. A hand-search of reference lists of relevant studies was also performed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Although some observational studies showed that inhibition of TNF-\u03b1 reduced pain and improved function, randomized controlled trials and a meta-analysis failed to demonstrate the superiority of anti-TNF-\u03b1 over placebo in this regard. Anti-TNF-\u03b1, however, reduced the risk of having invasive procedures such as discectomy and radicular block in cases of sciatica. Conversely, controlled studies showed moderate pain reduction and mild functional improvement with anti-NGF administration, but the side effect profile of anti-NGF was unfavorable compared with placebo.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Overall, anticytokine treatments have limited efficacy in patients with chronic low back pain with or without sciatica. However, larger and better-designed studies may need to be performed in specific patient subpopulations. Low back pain is particularly disabling in younger patients. This group therefore represents a potential target population for investigating the effectiveness of anticytokine therapies, especially where other pharmacological and nonpharmacological management strategies have failed.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/pm\/pny214","type":"journal-article","created":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T03:10:26Z","timestamp":1537758626000},"page":"1678-1686","source":"Crossref","is-referenced-by-count":24,"title":["Biologic Drugs as Analgesics for the Management of Low Back Pain and Sciatica"],"prefix":"10.1093","volume":"20","author":[{"given":"Theodoros","family":"Dimitroulas","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Dudley Group NHS Foundation Trust, Dudley, UK"},{"name":"Fourth Department of Internal Medicine, Hippokration Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tosin","family":"Lambe","sequence":"additional","affiliation":[{"name":"Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon H","family":"Raphael","sequence":"additional","affiliation":[{"name":"Department of Pain Medicine, Dudley Group NHS Foundation Trust, Dudley, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George D","family":"Kitas","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Dudley Group NHS Foundation Trust, Dudley, UK"},{"name":"Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, University of Manchester, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui V","family":"Duarte","sequence":"additional","affiliation":[{"name":"Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,12,20]]},"reference":[{"issue":"3","key":"2019090613250768400_pny214-B1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/ageing\/afj055","article-title":"Does back pain prevalence really decrease with increasing age? A systematic review","volume":"35","author":"Dionne","year":"2006","journal-title":"Age Ageing"},{"issue":"2","key":"2019090613250768400_pny214-B2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jval.2012.11.001","article-title":"Cost-effectiveness of cetuximab, cetuximab plus irinotecan, and panitumumab for third and further lines of treatment for KRAS wild-type patients with metastatic colorectal cancer","volume":"16","author":"Hoyle","year":"2013","journal-title":"Value Health"},{"issue":"2","key":"2019090613250768400_pny214-B3","first-page":"CD008686","article-title":"Red flags to screen for malignancy in patients with low\u2010back pain","author":"Henschke","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"2019090613250768400_pny214-B4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.mcna.2014.01.003","article-title":"Low back pain","volume":"98","author":"Golob","year":"2014","journal-title":"Med Clin North Am"},{"issue":"4","key":"2019090613250768400_pny214-B5","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3174\/ajnr.A4173","article-title":"Systematic literature review of imaging features of spinal degeneration in asymptomatic populations","volume":"36","author":"Brinjikji","year":"2015","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"2019090613250768400_pny214-B6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ner.12738","article-title":"Muscle control and non-specific chronic low back pain","volume":"21","author":"Russo","year":"2018","journal-title":"Neuromodulation"},{"key":"2019090613250768400_pny214-B7","volume-title":"Low Back Pain and Sciatica in over 16s: Assessment and Management","author":"National Guideline Centre (UK)","year":"2016"},{"issue":"1","key":"2019090613250768400_pny214-B8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/PHM.0b013e31827df8f5","article-title":"The chimera of low back pain etiology: A clinical rehabilitation perspective","volume":"92","author":"Negrini","year":"2013","journal-title":"Am J Phys Med Rehabil"},{"key":"2019090613250768400_pny214-B9","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-7091-1535-0","volume-title":"The Intervertebral Disc","author":"Shapiro","year":"2014"},{"issue":"2","key":"2019090613250768400_pny214-B10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.berh.2009.11.005","article-title":"Sciatica","volume":"24","author":"Valat","year":"2010","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"11","key":"2019090613250768400_pny214-B11","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/00007632-199318110-00005","article-title":"Autologous nucleus pulposus induces neurophysiologic and histologic changes in porcine cauda equina nerve roots","volume":"18","author":"Olmarker","year":"1993","journal-title":"Spine"},{"issue":"6","key":"2019090613250768400_pny214-B12","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s005860050106","article-title":"Early effects of nucleus pulposus application on spinal nerve root morphology and function","volume":"7","author":"Byr\u00f6d","year":"1998","journal-title":"Eur Spine J"},{"issue":"3","key":"2019090613250768400_pny214-B13","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jbspin.2005.03.004","article-title":"Pathophysiology of disk-related low back pain and sciatica. II. Evidence supporting treatment with TNF-\u03b1 antagonists","volume":"73","author":"Mulleman","year":"2006","journal-title":"Joint Bone Spine"},{"issue":"1","key":"2019090613250768400_pny214-B14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nrrheum.2013.160","article-title":"Role of cytokines in intervertebral disc degeneration: Pain and disc content","volume":"10","author":"Risbud","year":"2014","journal-title":"Nat Rev Rheumatol"},{"issue":"23","key":"2019090613250768400_pny214-B15","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1097\/00007632-200012010-00003","article-title":"Exogenous tumor necrosis factor-alpha mimics nucleus pulposus-induced neuropathology: Molecular, histologic, and behavioral comparisons in rats","volume":"25","author":"Igarashi","year":"2000","journal-title":"Spine"},{"issue":"5","key":"2019090613250768400_pny214-B16","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/01.brs.0000201260.10082.23","article-title":"Changes in pain behavior and histologic changes caused by application of tumor necrosis factor-alpha to the dorsal root ganglion in rats","volume":"31","author":"Murata","year":"2006","journal-title":"Spine"},{"issue":"8","key":"2019090613250768400_pny214-B17","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/00007632-200104150-00007","article-title":"Selective inhibition of tumor necrosis factor-\u03b1 prevents nucleus pulposus-induced thrombus formation, intraneural edema, and reduction of nerve conduction velocity: Possible implications for future pharmacologic treatment strategies of sciatica","volume":"26","author":"Olmarker","year":"2001","journal-title":"Spine"},{"issue":"1\u20132","key":"2019090613250768400_pny214-B18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.neulet.2005.03.012","article-title":"Effects of selective tumor necrosis factor-alpha inhibition to pain-behavioral changes caused by nucleus pulposus-induced damage to the spinal nerve in rats","volume":"382","author":"Murata","year":"2005","journal-title":"Neurosci Lett"},{"issue":"4","key":"2019090613250768400_pny214-B19","doi-asserted-by":"crossref","first-page":"R77.","DOI":"10.1186\/ar2275","article-title":"Catabolic cytokine expression in degenerate and herniated human intervertebral discs: IL-1\u03b2 and TNF\u03b1 expression profile","volume":"9","author":"Le Maitre","year":"2007","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"2019090613250768400_pny214-B20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/rheumatology\/keh013","article-title":"TNF-\u03b1 blockade for herniated intervertebral disc-induced sciatica: A way forward at last?","volume":"43","author":"Cooper","year":"2004","journal-title":"Rheumatology"},{"issue":"12","key":"2019090613250768400_pny214-B21","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1002\/art.23051","article-title":"Can sciatica induced by disc herniation be treated with tumor necrosis factor \u03b1 blockade?","volume":"56","author":"Goupille","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2019090613250768400_pny214-B22","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1523\/JNEUROSCI.08-02-00664.1988","article-title":"Expression of nerve growth factor receptors by Schwann cells of axotomized peripheral nerves: Ultrastructural location, suppression by axonal contact, and binding properties","volume":"8","author":"Taniuchi","year":"1988","journal-title":"J Neurosci"},{"issue":"2","key":"2019090613250768400_pny214-B23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0006-8993(81)90589-8","article-title":"Retinal ganglion cell response to axotomy and nerve growth factor antiserum treatment in the regenerating visual system of the goldfish (Carassius auratus): An in vivo and in vitro analysis","volume":"204","author":"Turner","year":"1981","journal-title":"Brain Res"},{"key":"2019090613250768400_pny214-B24","doi-asserted-by":"crossref","first-page":"e37.","DOI":"10.1016\/j.apmr.2006.08.216","article-title":"PR_191: C-Jun N-terminal kinase activation in dorsal root ganglion contributes to pain hypersensitivity","volume":"87","author":"Doya","year":"2006","journal-title":"Arch Phys Med Rehabil"},{"issue":"2","key":"2019090613250768400_pny214-B25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0304-3959(98)00164-X","article-title":"Effect of NGF and anti-NGF on neuropathic pain in rats following chronic constriction injury of the sciatic nerve","volume":"79","author":"Ro","year":"1999","journal-title":"Pain"},{"issue":"4","key":"2019090613250768400_pny214-B26","doi-asserted-by":"crossref","first-page":"R159.","DOI":"10.1186\/ar4674","article-title":"Increase of nerve growth factor levels in the human herniated intervertebral disc: Can annular rupture trigger discogenic back pain","volume":"16","author":"Aoki","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"2019090613250768400_pny214-B27","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/BRS.0b013e31817329f0","article-title":"Percutaneous lumbar zygapophysial (facet) joint neurotomy using radiofrequency current, in the management of chronic low back pain: A randomized double-blind trial","volume":"33","author":"Nath","year":"2008","journal-title":"Spine"},{"issue":"5","key":"2019090613250768400_pny214-B28","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00264-013-1811-y","article-title":"Is hybrid imaging (SPECT\/CT) a useful adjunct in the management of suspected facet joints arthropathy?","volume":"37","author":"Matar","year":"2013","journal-title":"Int Orthop"},{"issue":"2","key":"2019090613250768400_pny214-B29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.mehy.2007.05.014","article-title":"Modic changes, possible causes and relation to low back pain","volume":"70","author":"Albert","year":"2008","journal-title":"Med Hypotheses"},{"issue":"11","key":"2019090613250768400_pny214-B30","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","article-title":"Writing a narrative biomedical review: Considerations for authors, peer reviewers, and editors","volume":"31","author":"Gasparyan","year":"2011","journal-title":"Rheumatol Int"},{"key":"2019090613250768400_pny214-B31","author":"Effective Public Health Practice Project","year":"1998"},{"issue":"8","key":"2019090613250768400_pny214-B32","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1002\/art.27499","article-title":"Adalimumab in severe and acute sciatica: A multicenter, randomized, double\u2010blind, placebo\u2010controlled trial","volume":"62","author":"Genevay","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"9","key":"2019090613250768400_pny214-B33","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1136\/ard.2003.016451","article-title":"Efficacy of etanercept in the treatment of acute, severe sciatica: A pilot study","volume":"63","author":"Genevay","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2019090613250768400_pny214-B34","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1097\/ALN.0b013e3181a05aa0","article-title":"Randomized, double-blind, placebo-controlled, dose-response, and preclinical safety study of transforaminal epidural etanercept for the treatment of sciatica","volume":"110","author":"Cohen","year":"2009","journal-title":"Anesthesiology"},{"issue":"1","key":"2019090613250768400_pny214-B35","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/BSD.0b013e31819afdc4","article-title":"Tumor necrosis alpha-blocking agent (etanercept): A triple blind randomized controlled trial of its use in treatment of sciatica","volume":"23","author":"Okoro","year":"2010","journal-title":"J Spinal Disord Tech"},{"issue":"6","key":"2019090613250768400_pny214-B36","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/BRS.0b013e318238af83","article-title":"Epidural administration of spinal nerves with the tumor necrosis factor-alpha inhibitor, etanercept, compared with dexamethasone for treatment of sciatica in patients with lumbar spinal stenosis: A prospective randomized study","volume":"37","author":"Ohtori","year":"2012","journal-title":"Spine"},{"issue":"23","key":"2019090613250768400_pny214-B37","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1097\/01.brs.0000435140.61593.4c","article-title":"Randomized, double-blind, placebo-controlled, trial of transforaminal epidural etanercept for the treatment of symptomatic lumbar disc herniation","volume":"38","author":"Freeman","year":"2013","journal-title":"Spine"},{"issue":"19","key":"2019090613250768400_pny214-B38","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1097\/01.brs.0000141179.58778.6c","article-title":"Efficacy of infliximab for disc herniation-induced sciatica: One-year follow-up","volume":"29","author":"Korhonen","year":"2004","journal-title":"Spine"},{"issue":"24","key":"2019090613250768400_pny214-B39","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1097\/01.brs.0000245873.23876.1e","article-title":"The treatment of disc-herniation-induced sciatica with infliximab: One-year follow-up results of FIRST II, a randomized controlled trial","volume":"31","author":"Korhonen","year":"2006","journal-title":"Spine"},{"issue":"1","key":"2019090613250768400_pny214-B40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/1876532700901010009","article-title":"The efficacy of infliximab in sciatica induced by disc herniations located at L3\/4 or L4\/5: A small-scale randomized controlled trial","volume":"1","author":"Karppinen","year":"2009","journal-title":"Open Spine J"},{"issue":"8","key":"2019090613250768400_pny214-B41","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/01.BRS.0000058944.38900.CE","article-title":"Tumor necrosis factor-alpha monoclonal antibody, infliximab, used to manage severe sciatica","volume":"28","author":"Karppinen","year":"2003","journal-title":"Spine"},{"issue":"12","key":"2019090613250768400_pny214-B42","doi-asserted-by":"crossref","first-page":"E248","DOI":"10.1097\/01.BRS.0000127192.89438.FE","article-title":"Rapid resolution of chronic sciatica with intravenous infliximab after failed epidural steroid injections","volume":"29","author":"Atcheson","year":"2004","journal-title":"Spine"},{"issue":"11\u201312","key":"2019090613250768400_pny214-B43","first-page":"170","article-title":"Perispinal TNF-alpha inhibition for discogenic pain","volume":"133","author":"Tobinick","year":"2003","journal-title":"Swiss Med Wkly"},{"issue":"8","key":"2019090613250768400_pny214-B44","doi-asserted-by":"crossref","first-page":"551","DOI":"10.7326\/0003-4819-156-8-201204170-00397","article-title":"Epidural steroids, etanercept, or saline in subacute sciatica: A multicenter, randomized trial","volume":"156","author":"Cohen","year":"2012","journal-title":"Ann Intern Med"},{"issue":"4","key":"2019090613250768400_pny214-B45","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/annrheumdis-2011-200373","article-title":"Adalimumab in acute sciatica reduces the long-term need for surgery: A 3-year follow-up of a randomised double-blind placebo-controlled trial","volume":"71","author":"Genevay","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"2019090613250768400_pny214-B46","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.pain.2011.05.003","article-title":"Efficacy and safety of tanezumab in the treatment of chronic low back pain","volume":"152","author":"Katz","year":"2011","journal-title":"Pain"},{"issue":"7","key":"2019090613250768400_pny214-B47","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.pain.2013.03.006","article-title":"Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain","volume":"154","author":"Kivitz","year":"2013","journal-title":"Pain"},{"issue":"6","key":"2019090613250768400_pny214-B48","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.clinthera.2016.03.030","article-title":"Efficacy, safety, and tolerability of fulranumab as an adjunctive therapy in patients with inadequately controlled, moderate-to-severe chronic low back pain: A randomized, double-blind, placebo-controlled, dose-ranging, dose-loading phase II study","volume":"38","author":"Sanga","year":"2016","journal-title":"Clin Ther"},{"issue":"9","key":"2019090613250768400_pny214-B49","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1007\/s00586-013-2739-z","article-title":"A systematic review and meta-analysis of biological treatments targeting tumour necrosis factor \u03b1 for sciatica","volume":"22","author":"Williams","year":"2013","journal-title":"Eur Spine J"},{"issue":"7","key":"2019090613250768400_pny214-B50","doi-asserted-by":"crossref","first-page":"e103147.","DOI":"10.1371\/journal.pone.0103147","article-title":"Clinical significance of tumor necrosis factor-\u03b1 inhibitors in the treatment of sciatica: A systematic review and meta-analysis","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"2019090613250768400_pny214-B51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta15390","article-title":"The clinical effectiveness and cost-effectiveness of management strategies for sciatica: Systematic review and economic model","volume":"15","author":"Lewis","year":"2011","journal-title":"Health Technol Assess"},{"key":"2019090613250768400_pny214-B52","first-page":"1","article-title":"Subcutaneous Injection of Adalimumab Trial compared with Control (SCIATiC): A randomised controlled trial of adalimumab injection compared with placebo for patients receiving physiotherapy treatment for sciatica","volume":"21","author":"Williams","year":"2017","journal-title":"Health Technol Assess"},{"key":"2019090613250768400_pny214-B53","first-page":"E45","article-title":"Anti-nerve growth factor in the treatment of low back pain and radiculopathy: A systematic review and a meta-analysis","volume":"17","author":"Leite","year":"2014","journal-title":"Pain Physician"},{"issue":"9","key":"2019090613250768400_pny214-B54","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/rheumatology\/ker151","article-title":"Efficacy and tolerance of systemic steroids in sciatica: A systematic review and meta-analysis","volume":"50","author":"Roncoroni","year":"2011","journal-title":"Rheumatology"},{"issue":"3","key":"2019090613250768400_pny214-B55","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1399-6576.2012.02670.x","article-title":"New hypothesis of chronic back pain: Low pH promotes nerve ingrowth into damaged intervertebral disks","volume":"57","author":"Liang","year":"2013","journal-title":"Acta Anaesthesiol Scand"}],"container-title":["Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/painmedicine\/article-pdf\/20\/9\/1678\/29758195\/pny214.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T17:25:44Z","timestamp":1567790744000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/painmedicine\/article\/20\/9\/1678\/5253939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,20]]},"references-count":55,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,12,20]]},"published-print":{"date-parts":[[2019,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/pm\/pny214","relation":{},"ISSN":["1526-2375","1526-4637"],"issn-type":[{"value":"1526-2375","type":"print"},{"value":"1526-4637","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,9]]},"published":{"date-parts":[[2018,12,20]]}}}